Benjamin Podvin

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma.

Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma.

Journal: Biomarker research

Published: May 24, 2026

Mature plasmacytoid dendritic cell proliferations are also associated with T-cell acute lymphoblastic leukemia: towards an expanding range of associated neoplasms.

Mature plasmacytoid dendritic cell proliferations are also associated with T-cell acute lymphoblastic leukemia: towards an expanding range of associated neoplasms.

Journal: Haematologica

Published: May 04, 2026

TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.

TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.

Journal: Blood advances

Published: March 24, 2026

TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.

TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.

Journal: Blood advances

Published: March 24, 2026

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study.

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study.

Journal: HemaSphere

Published: February 26, 2026

Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights.

Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights.

Journal: American journal of hematology

Published: January 28, 2026

Response to Dr. Sorigue's Letter Regarding Our Article: "A New Diagnostic Approach for Myelodysplastic Neoplasms Using a Combination of Scores Based on Flow Cytometry and Automated Hematology Sysmex XN Analyzers".

Response to Dr. Sorigue's Letter Regarding Our Article: "A New Diagnostic Approach for Myelodysplastic Neoplasms Using a Combination of Scores Based on Flow Cytometry and Automated Hematology Sysmex XN Analyzers".

Journal: International journal of laboratory hematology

Published: April 28, 2025

Early T-precursor acute lymphoblastic leukemia with mature plasmacytoid dendritic cell proliferation.

Early T-precursor acute lymphoblastic leukemia with mature plasmacytoid dendritic cell proliferation.

Journal: Blood

Published: April 17, 2025

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Journal: European journal of haematology

Published: March 27, 2025

Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Journal: Leukemia

Published: January 04, 2025

NPM1 mutation subtype switch in acute myeloid leukemia.

NPM1 mutation subtype switch in acute myeloid leukemia.

Journal: Haematologica

Published: November 06, 2024

A New Diagnostic Approach for Myelodysplastic Neoplasms Using a Combination of Scores Based on Flow Cytometry and Automated Hematology Sysmex XN Analyzers.

A New Diagnostic Approach for Myelodysplastic Neoplasms Using a Combination of Scores Based on Flow Cytometry and Automated Hematology Sysmex XN Analyzers.

Journal: International journal of laboratory hematology

Published: July 10, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026